JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v6i2.3741ArticleAn Updated Overview of the Treatment of Colorectal and Gastric Cancer Using Saffronhttps://artdesignp.com/journal/JCNR/6/2/10.26689/jcnr.v6i2.3741DarroudiMahdieh,NazariElnaz,Khalili-TanhaNima,RezayiMajid,KhazaeiMajid2022622022-03-29Despite the increasing number of drugs and treatments available for cancer patients, the effect of cancer on the quality of life of patients and their life expectancy is significant. Moreover, many new therapeutic options have shown to have adverse effects without improving outcomes. These days, natural plants and chemopreventive drugs are commonly used. Chemoprevention is a new form of therapy that targets specific premalignant-malignant transformations. Plant-derived substances, such as polyphenols, flavonoids, carotenoids, alkaloids, etc., have a range of biological effects. Despite extensive studies on the anti-inflammatory effect of saffron carotenoids, they are also bioactive in some other ways, including the inhibition of tumor growth and the induction of cell death. In addition to interfering with a wide array of signaling molecules, this substance has pleiotropic effects: it inhibits pro-inflammatory molecules, transcription factors, enzymes, protein kinases, protein transport proteins, proteins that are crucial for cell survival, growth factors, proteins that regulate the cell cycle, and chemokines. Saffron has high oral bioavailability and is, therefore, suitable for treating gastrointestinal diseases. This antioxidant and anti-proliferative property of saffron makes it a promising chemopreventive agent for colorectal cancer. In contrast with in vitro studies devoted to saffron and in vivo studies on animal models, saffron has rarely been assessed in clinical studies dealing with gastrointestinal oncology. However, several clinical trials are in progress in this domain, although saffron has no approved medical indication as of yet.

Rios JL, Recio MC, Giner RM, et al., 1996, An Update Review of Saffron and Its Active Constituents. Phyther Res, 10(3): 189-193.

Moshiri M, Vahabzadeh M, Hosseinzadeh H, 2015, Clinical Applications of Saffron (Crocus Sativus) and Its Constituents: A Review. Drug Res (Stuttg), 65(06): 287-295. https://doi.org/10.1055/s-0034-1375681

Ghaffari S, Roshanravan N, 2019, Saffron; An Updated Review on Biological Properties with Special Focus on Cardiovascular Effects. Biomed Pharmacother, 109: 21-27.

Shakeri M, Tayer AH, Shakeri H, et al., 2020, Toxicity of Saffron Extracts on Cancer and Normal Cells: A Review Article. Asian Pacific J Cancer Prev, 21(7): 1867-1875.

Lu C, Ke L, Li J, et al., 2021, Saffron (Crocus Sativus L.) and Health Outcomes: A Meta-Research Review of Meta-Analyses and an Evidence Mapping Study. Phytomedicine, 91: 153699. https://doi.org/10.1016/j.phymed.2021.153699

Lambrianidou A, Koutsougianni F, Papapostolou I, et al., 2020, Recent Advances on the Anticancer Properties of Saffron (Crocus Sativus L.) and Its Major Constituents. Molecules, 26(1): 86.

Naeimi M, Shafiee M, Kermanshahi F, et al., 2019, Saffron (Crocus Sativus) in the Treatment of Gastrointestinal Cancers: Current Findings and Potential Mechanisms of Action. J Cell Biochem, 120: 16330-16339. https://doi.org/10.1002/JCB.29126

Pashirzad M, Shafiee M, Avan A, et al., 2019, Therapeutic Potency of Crocin in the Treatment of Inflammatory Diseases: Current Status and Perspective. J Cell Physiol, 234: 14601-14611. https://doi.org/10.1002/JCP.28177

Baena Ruiz R, Salinas Hernández P, 2016, Cancer Chemoprevention by Dietary Phytochemicals: Epidemiological Evidence. Maturitas, 94: 13-19.

Greenlee H, 2012, Natural Products for Cancer Prevention. Semin Oncol Nurs, 28(1): 29-44. https://doi.org/10.1016/j.soncn.2011.11.004

Lee BM, Park KK, 2003, Beneficial and Adverse Effects of Chemopreventive Agents. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 523-524: 265-278.

Finkel T, Serrano M, Blasco MA, 2007, The Common Biology of Cancer and Ageing. Nat, 448: 767-774. https://doi.org/10.1038/nature05985

Vitale G, Salvioli S, Franceschi C, 2013, Oxidative Stress and the Ageing Endocrine System. Nat Rev Endocrinol, 9: 228-240. https://doi.org/10.1038/nrendo.2013.29

Rezaei N, Avan A, Pashirzad M, et al., 2019, Crocin as a Novel Therapeutic Agent Against Colitis. Drug and Chemical Toxicology, 43(5): 514-521. https://doi.org/10.1080/01480545.2018.1527850

Amerizadeh F, Rezaei N, Rahmani F, et al., 2018, Crocin Synergistically Enhances the Antiproliferative Activity of 5-Flurouracil Through Wnt/PI3K Pathway in a Mouse Model of Colitis-Associated Colorectal Cancer. J Cell Biochem, 119: 10250-10261. https://doi.org/10.1002/JCB.27367

Yang Y, Karakhanova S, Hartwig W, et al., 2016, Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy. J Cell Physiol, 231: 2570-2581. https://doi.org/10.1002/JCP.25349

Du Y, Long Q, Zhang L, et al., 2015, Curcumin Inhibits Cancer-Associated Fibroblast-Driven Prostate Cancer Invasion through MAOA/mTOR/HIF-1? Signaling. Int J Oncol, 47: 2064-2072. https://doi.org/10.3892/ijo.2015.3202

Weir HK, Thompson TD, Soman A, et al., 2015, The Past, Present, and Future of Cancer Incidence in the United States: 1975 through 2020. Cancer, 121(11): 1827-1837. https://doi.org/10.1002/cncr.29258

Williams J, Smith F, Kumar S, et al., 2017, Are MicroRNAs True Sensors of Ageing and Cellular Senescence?. Ageing Res Rev, 35: 350-363.

Bhatti JS, Bhatti GK, Reddy PH, 2017, Mitochondrial Dysfunction and Oxidative Stress in Metabolic Disorders – A Step towards Mitochondria Based Therapeutic Strategies. Biochim Biophys Acta Mol Basis Dis, 1863(5): 1066-1077.

Liu RH, 2003, Health Benefits of Fruit and Vegetables are from Additive and Synergistic Combinations of Phytochemicals. American Journal of Clinical Nutrition, 78(3): 517S-520S.

Colapietro A, Mancini A, D’Alessandro AM, et al., 2019, Crocetin and Crocin from Saffron in Cancer Chemotherapy and Chemoprevention. Anticancer Agents Med Chem, 19(1): 38-47. https://doi.org/10.2174/1871520619666181231112453

Bolhassani A, Khavari A, Bathaie SZ, 2014, Saffron and Natural Carotenoids: Biochemical Activities and Anti-Tumor Effects. Biochim Biophys Acta Rev Cancer, 1845(1): 20-30.

Vajravijayan S, Pletnev S, Pletnev VZ, et al., 2016, Structural Analysis of ?-Prism Lectin from Colocasia Esculenta (L.) S Chott. Int J Biol Macromol, 91: 518-523. https://doi.org/10.1016/j.ijbiomac.2016.05.048

Bajbouj K, Schulze-Luehrmann J, Diermeier S, et al., 2012, The Anticancer Effect of Saffron in Two P53 Isogenic Colorectal Cancer Cell Lines. BMC Complement Altern Med, 12(1): 1-9. https://doi.org/10.1186/1472-6882-12-69

Garcia-Olmo DC, Riese HH, Escribano J, et al., 1999, Effects of Long-Term Treatment of Colon Adenocarcinoma with Crocin, a Carotenoid from Saffron (Crocus Sativus L.): An Experimental Study in the Rat. Nutr Cancer, 35(2): 120-126. https://doi.org/10.1207/s15327914nc352_4

Abdullaev Jafarova F, Caballero-Ortega H, Riverón-Negrete L, et al., 2002, Evaluation In Vitro of Chemopreventive Potenial of Saffron. Rev Investig Clin, 54(5): 430-436.

Koch A, Gandesiri M, Schneider-Stock R, 2015, Defective Autophagosome Formation in p53-Null Colorectal Cancer Reinforces Crocin-Induced Apoptosis. Int J Mol Sci, 16(1): 1544-1561. https://doi.org/10.3390/IJMS16011544

Ray P, Guha D, Chakraborty J, et al., 2016, Crocetin Exploits p53-Induced Death Domain (PIDD) and FAS-Associated Death Domain (FADD) Proteins to Induce Apoptosis in Colorectal Cancer. Sci Rep, 6: 32979. https://doi.org/10.1038/srep32979

Li CY, Huang WF, Wang QL, et al., 2012, Crocetin Induces Cytotoxicity in Colon Cancer Cells Via p53-Independent Mechanisms. Asian Pacific J Cancer Prev, 13(8): 3757-3761. https://doi.org/10.7314/APJCP.2012.13.8.3757

Rastgoo M, Hosseinzadeh H, Alavizadeh H, et al., 2013, Antitumor Activity of PEGylated Nanoliposomes Containing Crocin in Mice Bearing C26 Colon Carcinoma. Planta Med, 79(6): 447-451. https://doi.org/10.1055/s-0032-1328363

Barel F, Auffret A, Cariou M, et al., 2019, High Reproducibility is Attainable in Assessing Histoprognostic Parameters of pT1 Colorectal Cancer Using Routine Histopathology Slides and Immunohistochemistry Analyses. Pathology, 51(1): 46-54. https://doi.org/10.1016/j.pathol.2018.10.007

Sroda-Pomianek K, Palko-Labuz A, Po?a A, et al., 2020, TMPE Derived from Saffron Natural Monoterpene as Cytotoxic and Multidrug Resistance Reversing Agent in Colon Cancer Cells. Int J Mol Sci, 21(20): 1-17. https://doi.org/10.3390/ijms21207529

Gullu N, Kobelt D, Brim H, et al., 2020, Saffron Crudes and Compounds Restrict MACC1-Dependent Cell Proliferation and Migration of Colorectal Cancer Cells. Cells, 9(8): 1829. https://doi.org/10.3390/cells9081829

Amin A, Farrukh A, Murali C, et al., 2021, Saffron and Its Major Ingredients’ Effect on Colon Cancer Cells with Mismatch Repair Deficiency and Microsatellite Instability. Molecules, 26(13): 3855. https://doi.org/10.3390/molecules26133855

Bathaie SZ, Miri H, Mohagheghi MA, et al., 2013, Saffron Aqueous Extract Inhibits the Chemically-Induced Gastric Cancer Progression in the Wistar Albino Rat. Iran J Basic Med Sci, 16(1): 27-38.

Hoshyar R, Bathaie SZ, Sadeghizadeh M, 2013, Crocin Triggers the Apoptosis Through Increasing the Bax/Bcl-2 Ratio and Caspase Activation in Human Gastric Adenocarcinoma, AGS, Cells. DNA and Cell Biology, 32(2): 50-57. https://doi.org/10.1089/dna.2012.1866

Luo Y, Cui S, Tang F, et al., 2017, The Combination of Crocin with Cisplatin Suppresses Growth of Gastric Carcinoma Cell Line BGC-823 and Promotes Cell Apoptosis. Pak J Pharm Sci, 30(5): 1629-1634.

Li J, Yap SQ, Yoong SL, et al., 2012, Carbon Nanotube Bottles for Incorporation, Release and Enhanced Cytotoxic Effect of Cisplatin. Carbon, 50(4): 1625-1634. https://doi.org/10.1016/j.carbon.2011.11.043